Q1 2025 IM Cannabis Corp Earnings Call Transcript
Key Points
- IM Cannabis Corp (IMCC) achieved a net profit in Q1 2025, marking a significant turnaround from previous losses.
- The company reported an 87% improvement in gross margin compared to Q1 2024.
- Revenue from the German market increased by 569% versus Q1 2024, highlighting successful market expansion.
- Operating expenses decreased by approximately 56% compared to Q1 2024, indicating improved cost management.
- Adjusted EBITDA turned positive, with a profit of 0.6 million CAD compared to a loss of 2.2 million CAD in Q1 2024.
- Revenue from the Israeli market declined by 56% compared to Q1 2024, impacting overall revenue distribution.
- The decrease in Israeli revenue was partly due to the cancellation of the organin bill, resulting in a revenue drop of approximately 3.5 million CAD.
- Total liabilities increased by 16% as of March 31, 2025, compared to December 31, 2024.
- The company faces ongoing challenges in balancing its operations between different markets, as seen in the shifting focus from Israel to Germany.
- Despite profitability, the company still needs to secure additional sources of capital and financing to support future operations.
Good morning and welcome to IM Cannabis Corp's first quarter 2025 earnings conference call. Today's conference call is being recorded.
At this time, I would like to turn the conference over to Anna Taranko, Director of Investor and Public Relations. Anna.
&
Good morning and thank you operator. Joining me for today's call are IM Cannabis, Chief Executive Officer Oren Shuster and Chief Financial Officer, Uri Birenberg. The earnings and press release that accompanies this call is available on the investor relations section of our website at investors.i mcannabis.com.
Today's call will include estimates and other forward-looking information and statements, including statements concerning future results of operations, economic conditions and anticipated courses of action and are based on assumptions, expectations, estimates and projections as the date here.
This information may involve known and unknown risks, uncertainties and other factors that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
